Human RALA/RAL ORF/cDNA clone-Lentivirus plasmid (NM_005402.3)
Cat. No.: pGMLP005819
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human RALA/RAL Lentiviral expression plasmid for RALA lentivirus packaging, RALA lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.
Go to
RALA/RAL products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
Catalog ID | pGMLP005819 |
Gene Name | RALA |
Accession Number | NM_005402.3 |
Gene ID | 5898 |
Species | Human |
Product Type | Lentivirus plasmid (overexpression) |
Insert Length | 621 bp |
Gene Alias | RAL |
Fluorescent Reporter | ZsGreen |
Mammalian Cell Selection | Puromyocin |
Fusion Tag | 3xflag (C-Terminal) |
Promoter | CMV |
Resistance | Amplicin |
ORF Nucleotide Sequence | ATGGCTGCAAATAAGCCCAAGGGTCAGAATTCTTTGGCTTTACACAAAGTCATCATGGTGGGCAGTGGTGGCGTGGGCAAGTCAGCTCTGACTCTACAGTTCATGTACGATGAGTTTGTGGAGGACTATGAGCCTACCAAAGCAGACAGCTATCGGAAGAAGGTAGTGCTAGATGGGGAGGAAGTCCAGATCGATATCTTAGATACAGCTGGGCAGGAGGACTACGCTGCAATTAGAGACAACTACTTCCGAAGTGGGGAGGGGTTCCTCTGTGTTTTCTCTATTACAGAAATGGAATCCTTTGCAGCTACAGCTGACTTCAGGGAGCAGATTTTAAGAGTAAAAGAAGATGAGAATGTTCCATTTCTACTGGTTGGTAACAAATCAGATTTAGAAGATAAAAGACAGGTTTCTGTAGAAGAGGCAAAAAACAGAGCTGAGCAGTGGAATGTTAACTACGTGGAAACATCTGCTAAAACACGAGCTAATGTTGACAAGGTATTTTTTGATTTAATGAGAGAAATTCGAGCGAGAAAGATGGAAGACAGCAAAGAAAAGAATGGAAAAAAGAAGAGGAAAAGTTTAGCCAAGAGAATCAGAGAAAGATGCTGCATTTTATAA |
ORF Protein Sequence | MAANKPKGQNSLALHKVIMVGSGGVGKSALTLQFMYDEFVEDYEPTKADSYRKKVVLDGEEVQIDILDTAGQEDYAAIRDNYFRSGEGFLCVFSITEMESFAATADFREQILRVKEDENVPFLLVGNKSDLEDKRQVSVEEAKNRAEQWNVNYVETSAKTRANVDKVFFDLMREIRARKMEDSKEKNGKKKRKSLAKRIRERCCIL |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
---|---|---|
Target Antibody | GM-Tg-g-MP2279-Ab | Anti-RALA/ RAL monoclonal antibody |
Target Antigen | GM-Tg-g-MP2279-Ag | RALA VLP (virus-like particle) |
ORF Viral Vector | pGMLP000857 | Human RALA Lentivirus plasmid |
ORF Viral Vector | pGMLP005654 | Human RALA Lentivirus plasmid |
ORF Viral Vector | pGMLP005819 | Human RALA Lentivirus plasmid |
ORF Viral Vector | vGMLP000857 | Human RALA Lentivirus particle |
ORF Viral Vector | vGMLP005654 | Human RALA Lentivirus particle |
ORF Viral Vector | vGMLP005819 | Human RALA Lentivirus particle |
Target information
Target ID | GM-MP2279 |
Target Name | RALA |
Gene Group Identifier (Target Gene ID in Homo species) |
5898 |
Gene ID |
100051360 (Equus caballus), 101091003 (Felis catus), 475875 (Canis lupus familiaris), 538477 (Bos taurus) 56044 (Mus musculus), 5898 (Homo sapiens), 703440 (Macaca mulatta), 81757 (Rattus norvegicus) |
Gene Symbols & Synonyms | RALA,Rala,Ral,Rasl1,3010001O15Rik,RAL,HINCONS |
Target Alternative Names | RALA,Ras-related protein Ral-A,RAL,HINCONS |
Uniprot Accession |
P11233,P63321,P63322
Additional SwissProt Accessions: P63321,P11233,P63322 |
Uniprot Entry Name | |
Protein Sub-location | Transmembrane Protein |
Category | |
Disease | cancer |
Disease from KEGG | Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, Pathways in cancer, Colorectal cancer, Pancreatic cancer |
Gene Ensembl | ENSECAG00000017044, ENSCAFG00845019538, ENSBTAG00000006661, ENSMUSG00000008859, ENSG00000006451, ENSMMUG00000050621 |
Target Classification | Tumor-associated antigen (TAA) |
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.